{"nct_id":"NCT04074330","title":"A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma","status":"TERMINATED","status_verified_date":"2024-05","start_date":"2019-10-15","start_date_type":"ACTUAL","primary_completion_date":"2023-04-26","primary_completion_date_type":"ACTUAL","completion_date":"2023-04-26","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["TAK"]}